These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 18419401)

  • 1. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS
    Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of varicella vaccination in the United States.
    Hambleton S; Gershon AA
    Semin Pediatr Infect Dis; 2005 Jan; 16(1):38-43. PubMed ID: 15685148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002.
    Jumaan AO; Yu O; Jackson LA; Bohlke K; Galil K; Seward JF
    J Infect Dis; 2005 Jun; 191(12):2002-7. PubMed ID: 15897984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of varicella vaccination on herpes zoster incidence.
    Wagenpfeil S; Neiss A; Wutzler P
    Clin Microbiol Infect; 2004 Nov; 10(11):954-60. PubMed ID: 15521996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination.
    Leung J; Harpaz R; Molinari NA; Jumaan A; Zhou F
    Clin Infect Dis; 2011 Feb; 52(3):332-40. PubMed ID: 21217180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.
    Guzzetta G; Poletti P; Merler S; Manfredi P
    Am J Epidemiol; 2016 Apr; 183(8):765-73. PubMed ID: 26994062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella prevention in the United States: a review of successes and challenges.
    Marin M; Meissner HC; Seward JF
    Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.